Delivery Order SPE2DE24D0021-SPE2D625F3HBD
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $5.5K for SOFIA 2 Flu + SARS Antigen Fluorescent I testing supplies under a fixed-price contract with economic price adjustment provisions. The award, issued on September 3, 2025, by the Medical Supply Chain, a defense-focused component within the federal government, is scheduled for completion by October 30, 2025, with performance taking place in Pittsburgh, PA. This delivery order represents a child contract,...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,658.76 on August 8, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price delivery order with economic price adjustment serves the Medical Supply Chain, a defense-oriented federal agency, with performance to be completed by October 6, 2025, at Fisher Scientific's Pittsburgh, Pennsylvania facility. The contract represents a child award under a larger vehicle and carries no...
- The U.S. Department of Defense's Medical Supply Chain has awarded a delivery order valued at $1.65K to Fisher Scientific Company L.L.C. for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic supplies. This fixed-price delivery order with economic price adjustment capability is scheduled for completion by October 22, 2025, and will be performed at Fisher Scientific's facility in Pittsburgh, Pennsylvania. The award represents a child contract under a larger vehicle structure, with no small...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract on August 14, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies with a ceiling value of $4,400. The contract, which operates under a fixed-price structure with economic price adjustment provisions, is scheduled for completion by October 10, 2025, and will be performed in Pittsburgh, Pennsylvania. This delivery order was issued without a set-aside designation, reflecting Fisher Scientific's...
- Fisher Scientific Company L.L.C., a major supplier of laboratory supplies and scientific equipment to federal agencies, received a delivery order award valued at $1,100.00 from the Medical Supply Chain, a defense-oriented federal agency, on August 14, 2025. The contract covers the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent I testing supplies and is structured as a fixed-price delivery order with economic price adjustment provisions. Performance will be completed in Pittsburgh,...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $4,423.36 on July 31, 2025, for the supply of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. This fixed-price delivery order with economic price adjustment will be performed in Pittsburgh, Pennsylvania, and is scheduled for completion by September 26, 2025. The contract was awarded without a set-aside designation through open competition to the Medical Supply Chain, a defense-focused federal agency. As a...
- Fisher Scientific Company L.L.C. was awarded a $4,400 fixed-price delivery order with economic price adjustment authority for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic supplies on September 4, 2025. The contract, which carries no set-aside designation, is a child award under a larger vehicle and will be performed at Fisher Scientific's Pittsburgh, Pennsylvania location, with an ultimate completion date of October 31, 2025. The funding agency is the Department of Defense Medical...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,300.00 on August 18, 2025, for the procurement of SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. This fixed-price contract with economic price adjustment carries an ultimate completion date of October 15, 2025, and will be performed in Pittsburgh, Pennsylvania. The contract is funded through the Medical Supply Chain, a defense-oriented federal agency, and is structured as a child contract under a...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $2,200 to Fisher Scientific Company L.L.C. on September 10, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent I diagnostic testing supplies. The contract, which is not set-aside and carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by November 6, 2025, with performance to be completed in Pittsburgh, Pennsylvania. Fisher Scientific, a major supplier of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,300 on August 27, 2025, for the procurement of Sofia 2 Flu + SARS Antigen Fluorescent testing supplies. This fixed-price contract with economic price adjustment provisions will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of October 24, 2025. The contract was funded by the Medical Supply Chain division within the Department of Defense and was awarded through open competition with no set-aside...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F3HBDDelivery Order
Fisher Scientific Company L.L.C., a major federal supplier of laboratory and medical equipment, was awarded a delivery order valued at $5,500 on September 12, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent immunodiagnostic supplies. This fixed-price delivery order with economic price adjustment provision will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of November 10, 2025. The contract was awarded without a set-aside designation, indicating open competition. The funding agency is the Defense Medical Supply Chain, a defense-related entity within the federal government. This delivery order represents a task order issued under a larger contract vehicle, as indicated by its child contract designation. Fisher Scientific's extensive history supplying specialized diagnostic and laboratory products to federal agencies, including the National Institutes of Health, Department of Veterans Affairs, and other defense-related organizations, demonstrates the company's capabilities in medical supply provision. The SOFIA 2 platform supplies referenced in this award support rapid multiplex antigen testing for influenza and SARS-related pathogens, reflecting continued federal investment in diagnostic capacity for infectious disease detection and response.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 9/12/25 |